About Achilles Therapeutics (ACHL)
Achilles Therapeutics PLC provides pharmaceuticals products. The Company offers therapies that target truncal tumour neo-antigens. Achilles Therapeutics serves customers in the United Kingdom.
- USD0.92
- USD0.95
- USD0.90
- USD3.45
- -19.10%
- --
- 94.17k
- 244.77k
- 33M
- 0.75
- -70.00%
Stock News
yesterday
: Virgin Orbit stock plunges after report says company will cease operations
MarketWatch
yesterday
: Donald Trump reportedly indicted in Stormy Daniels case — first former U.S. president to ever be criminally charged
MarketWatch
yesterday
NY grand jury indicts Trump in hush money payment case
CNBC
yesterday
Earnings Results: Shares of right-wing social platform Rumble rally nearly 30% following Q4 results
MarketWatch
More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
